Orbimed Advisors Llc (CIK 0001055951)

Latest company ownership

Shares held
7,663,349
Last filed at
May 20, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
PASG - Passage BIO, Inc.
Role: 10% Owner
Shares held
6,066,343
Last filed at
Jun 26, 2025
Confidence Score
46.9
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
5,193,946
Last filed at
Dec 10, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
Shares held
4,975,291
Last filed at
Oct 27, 2025
Confidence Score
20.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
4,901,310
Last filed at
Jun 6, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
VRNA - Verona Pharma plc
Role: Director
Shares held
3,777,778
Last filed at
May 15, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q4 2025Q4
Shares held
3,596,886
Last filed at
Nov 26, 2025
Confidence Score
24.3
2025Q4
Confidence Score History
2025Q1 2025Q4
Shares held
3,571,428
Last filed at
Nov 8, 2021
Confidence Score
48.4
2025Q4
Confidence Score History
2020Q2 2025Q4
KALA - KALA BIO, Inc.
Role: 10% Owner
Shares held
3,447,840
Last filed at
Feb 12, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4
NPCE - NeuroPace Inc
Role: 10% Owner
Shares held
3,238,199
Last filed at
May 16, 2025
Confidence Score
48.5
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
3,073,298
Last filed at
Sep 2, 2025
Confidence Score
59.4
2025Q4
Confidence Score History
2025Q3 2025Q4
ACET - Adicet Bio, Inc.
Role: 10% Owner
Shares held
2,930,527
Last filed at
Oct 10, 2025
Confidence Score
87.5
2025Q4
Confidence Score History
2018Q1 2025Q4
Shares held
2,750,079
Last filed at
May 24, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
TELA - TELA Bio, Inc.
Role: 10% Owner
Shares held
2,407,242
Last filed at
Jul 2, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
IMA - ImageneBio, Inc.
Role: Director
Shares held
2,346,399
Last filed at
Sep 21, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
2,212,571
Last filed at
Mar 31, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
ALEC - Alector, Inc.
Role: 10% Owner
Shares held
1,906,718
Last filed at
Apr 16, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q1 2025Q4
ETNB - 89bio, Inc.
Role: 10% Owner
Shares held
1,829,436
Last filed at
Jan 27, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
GLTO - Galecto, Inc.
Role: 10% Owner
Shares held
1,510,375
Last filed at
Aug 17, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
1,469,524
Last filed at
Feb 21, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
Shares held
1,397,684
Last filed at
Jul 1, 2025
Confidence Score
48.5
2025Q4
Confidence Score History
2016Q1 2025Q4
Shares held
1,348,326
Last filed at
Nov 29, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
CALC - CalciMedica, Inc.
Role: 10% Owner
Shares held
846,574
Last filed at
Sep 29, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
817,000
Last filed at
Feb 14, 2013
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q4 2025Q4
UPB - Upstream Bio, Inc.
Role: Director
Shares held
789,833
Last filed at
Oct 17, 2024
Confidence Score
50.1
2025Q4
Confidence Score History
2024Q4 2025Q4
Shares held
755,635
Last filed at
Jul 17, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
747,887
Last filed at
Feb 19, 2025
Confidence Score
50.5
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
708,201
Last filed at
Jun 29, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
564,780
Last filed at
May 13, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
538,646
Last filed at
Dec 3, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
526,300
Last filed at
May 24, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
469,615
Last filed at
Jan 31, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q1 2025Q4
Shares held
443,792
Last filed at
Apr 4, 2025
Confidence Score
52.1
2025Q4
Confidence Score History
2021Q1 2025Q4
NXTC - NextCure, Inc.
Role: Director
Shares held
442,438
Last filed at
May 13, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
Shares held
415,142
Last filed at
Jun 28, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
252,858
Last filed at
Aug 15, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
Shares held
231,098
Last filed at
Dec 30, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
186,541
Last filed at
Mar 26, 2025
Confidence Score
49.4
2025Q4
Confidence Score History
2023Q1 2025Q4
SIBN - SI-BONE, Inc.
Role: Director
Shares held
179,404
Last filed at
Oct 19, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q4 2025Q4
Shares held
119,522
Last filed at
Aug 15, 2024
Confidence Score
25.6
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
96,190
Last filed at
Sep 8, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
38,870
Last filed at
May 2, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q3 2025Q4
AMRN - AMARIN CORP PLC\UK
Role: Director
Shares held
5,700
Last filed at
Sep 5, 2012
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q2 2025Q4
Shares held
0
Last filed at
Apr 14, 2025
Confidence Score
48.4
2025Q4
Confidence Score History
2018Q1 2025Q4
GKOS - GLAUKOS Corp
Role: Director
Shares held
0
Last filed at
Mar 6, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 17, 2025 Dec 19, 2025 Sionna Therapeutics, Inc. Director Sell 47.5 -1,875 -0.05% ✗ $83.4K
Nov 21, 2025 Dec 18, 2025 Keros Therapeutics, Inc. Director Sell 17.5 -214,522 -21.06% ✗ $3.8M
Nov 24, 2025 Nov 26, 2025 Sionna Therapeutics, Inc. Director Sell 17.5 -108,073 -2.92% ✗ $4.8M
Oct 23, 2025 Oct 27, 2025 PMV Pharmaceuticals, Inc. 10% Owner Sell 17.5 -1,000,000 -16.74% ✗ $1.5M
Oct 8, 2025 Oct 10, 2025 Adicet Bio, Inc. 10% Owner Buy 100.0 +5,000,000 58.71% ✗ $5M
Sep 10, 2025 Sep 12, 2025 PMV Pharmaceuticals, Inc. 10% Owner Sell 20.0 -500,000 -7.72% ✗ $900K
Aug 25, 2025 Sep 2, 2025 Shattuck Labs, Inc. Director Buy 100.0 +6,306,127 100.00% ✗ $5.5M
Jun 27, 2025 Jul 1, 2025 Corvus Pharmaceuticals, Inc. Director Sell 17.5 -1,176,332 -14.10% ✗ $4.9M
Jun 24, 2025 Jun 26, 2025 Passage BIO, Inc. 10% Owner Sell 22.5 -583,657 -8.78% ✗ $197.2K
May 14, 2025 May 16, 2025 NeuroPace Inc 10% Owner Sell 17.5 -168,136 -4.94% ✗ $2.7M
Apr 22, 2025 Apr 24, 2025 Passage BIO, Inc. 10% Owner Sell 22.5 -235,572 -3.42% ✗ $78.7K
Apr 15, 2025 Apr 17, 2025 Passage BIO, Inc. 10% Owner Sell 26.3 -149,054 -2.12% ✗ $49.7K
Apr 10, 2025 Apr 14, 2025 Xtant Medical Holdings, Inc. 10% Owner Sell 15.0 -73,114,592 -100.00% ✗ $30.7M
Apr 9, 2025 Apr 11, 2025 Compass Therapeutics, Inc. Director Sell 16.3 -3,571,428 -100.00% ✗ $5.7M
Apr 3, 2025 Apr 4, 2025 Edgewise Therapeutics, Inc. Director Buy 95.0 +496,771 3.37% ✗ $10M
Mar 24, 2025 Mar 26, 2025 Disc Medicine, Inc. Director Sell 37.5 -5,738 -0.40% ✗ $310.5K
Mar 19, 2025 Mar 21, 2025 Disc Medicine, Inc. Director Sell 17.5 -52,429 -1.21% ✗ $2.8M
Mar 10, 2025 Mar 12, 2025 Disc Medicine, Inc. Director Sell 15.0 -312,384 -3.87% ✗ $17M
Feb 14, 2025 Feb 19, 2025 MBX Biosciences, Inc. Director Buy 87.5 +190,672 1.87% ✗ $2M
Feb 10, 2025 Feb 10, 2025 Sionna Therapeutics, Inc. Director Buy 100.0 +550,000 17.43% ✗ $9.9M
Jan 10, 2025 Jan 14, 2025 Passage BIO, Inc. 10% Owner Sell 22.5 -223,219 -3.08% ✗ $142.2K
Jan 6, 2025 Jan 8, 2025 Passage BIO, Inc. 10% Owner Sell 22.5 -147,024 -1.99% ✗ $103.3K
Dec 20, 2024 Dec 26, 2024 Passage BIO, Inc. 10% Owner Sell 22.5 -230,321 -3.02% ✗ $138.2K
Dec 9, 2024 Dec 11, 2024 Passage BIO, Inc. 10% Owner Sell 32.5 -62,276 -0.81% ✗ $52K
Dec 4, 2024 Dec 6, 2024 Passage BIO, Inc. 10% Owner Sell 22.5 -97,103 -1.25% ✗ $77.3K
Oct 15, 2024 Oct 17, 2024 Upstream Bio, Inc. Director Buy 100.0 +825,000 16.95% ✗ $14M
Sep 19, 2024 Sep 23, 2024 Passage BIO, Inc. 10% Owner Sell 36.3 -39,300 -0.50% ✗ $27.9K
Sep 16, 2024 Sep 18, 2024 Passage BIO, Inc. 10% Owner Sell 22.5 -200,131 -2.49% ✗ $146.7K
Sep 16, 2024 Sep 17, 2024 MBX Biosciences, Inc. Director Buy 100.0 +750,000 24.49% ✗ $12M
Aug 26, 2024 Aug 28, 2024 ARS Pharmaceuticals, Inc. Director Sell 17.5 -83,695 -100.00% ✗ $1.1M
Aug 21, 2024 Aug 23, 2024 ARS Pharmaceuticals, Inc. Director Sell 15.0 -868,682 -91.21% ✗ $11.5M
Aug 13, 2024 Aug 15, 2024 Keros Therapeutics, Inc. Director Sell 15.0 -250,000 -19.70% ✗ $11M
Aug 13, 2024 Aug 15, 2024 scPharmaceuticals Inc. 10% Owner Buy 95.0 +500,000 8.99% ✗ $2M
Jul 15, 2024 Jul 17, 2024 Terns Pharmaceuticals, Inc. Director Sell 37.5 -56,164 -0.37% ✗ $561.6K
Jun 28, 2024 Jul 2, 2024 TELA Bio, Inc. 10% Owner Sell 17.5 -428,300 -15.10% ✗ $2M
Jun 17, 2024 Jun 20, 2024 Disc Medicine, Inc. Director Buy 92.5 +83,334 4.90% ✗ $3M
May 16, 2024 May 20, 2024 Enliven Therapeutics, Inc. Director Sell 15.0 -1,033,300 -11.54% ✗ $22.9M
May 1, 2024 May 3, 2024 NeuroPace Inc 10% Owner Sell 30.0 -29,206 -0.85% ✗ $409.4K
Apr 24, 2024 Apr 26, 2024 NeuroPace Inc 10% Owner Sell 51.3 -1,781 -0.05% ✗ $25K
Apr 19, 2024 Apr 23, 2024 NeuroPace Inc 10% Owner Sell 20.0 -64,653 -1.85% ✗ $913.1K
Apr 16, 2024 Apr 18, 2024 NeuroPace Inc 10% Owner Sell 40.0 -16,992 -0.48% ✗ $238.2K
Apr 11, 2024 Apr 15, 2024 NeuroPace Inc 10% Owner Sell 16.3 -485,000 -12.11% ✗ $7M
Jan 30, 2024 Jan 31, 2024 ArriVent BioPharma, Inc. Director Buy 100.0 +444,444 17.21% ✗ $8M
Jan 25, 2024 Jan 26, 2024 Adicet Bio, Inc. Director Buy 100.0 +3,125,000 47.01% ✗ $7.5M
Jan 23, 2024 Jan 25, 2024 Edgewise Therapeutics, Inc. Director Buy 92.5 +454,545 3.25% ✗ $5M
Dec 18, 2023 Dec 20, 2023 Disc Medicine, Inc. Director Sell 47.5 -1,724 -0.10% ✗ $102.1K
Dec 14, 2023 Dec 15, 2023 Disc Medicine, Inc. Director Sell 15.0 -433,200 -20.29% ✗ $24.6M
Dec 12, 2023 Dec 14, 2023 Disc Medicine, Inc. Director Sell 16.3 -134,200 -2.11% ✗ $7.9M
Nov 22, 2023 Nov 24, 2023 PMV Pharmaceuticals, Inc. 10% Owner Sell 22.5 -87,786 -100.00% ✗ $195.8K
Oct 2, 2023 Oct 4, 2023 NeuroPace Inc 10% Owner Sell 40.0 -8,314 -0.21% ✗ $75.4K
Aug 29, 2023 Aug 31, 2023 ARS Pharmaceuticals, Inc. Director Buy 95.0 +500,000 6.65% ✗ $3.1M
Aug 15, 2023 Aug 17, 2023 Galecto, Inc. 10% Owner Sell 20.0 -822,680 -26.87% ✗ $617K
Jul 31, 2023 Aug 2, 2023 Galecto, Inc. 10% Owner Sell 20.0 -209,400 -6.29% ✗ $628.2K
Jul 25, 2023 Jul 27, 2023 Galecto, Inc. 10% Owner Sell 22.5 -39,200 -1.16% ✗ $114.5K
Jul 13, 2023 Jul 17, 2023 Galecto, Inc. 10% Owner Sell 20.0 -194,700 -5.46% ✗ $467.3K
Jun 27, 2023 Jun 29, 2023 Adicet Bio, Inc. Director Buy 100.0 +875,000 12.10% ✗ $1.8M
Jun 27, 2023 Jun 29, 2023 Passage BIO, Inc. 10% Owner Buy 100.0 +1,192,577 17.43% ✗ $1M
May 22, 2023 May 24, 2023 Prelude Therapeutics Inc Director Buy 95.0 +869,565 9.40% ✗ $5M
May 11, 2023 May 15, 2023 Verona Pharma plc Director Sell 16.3 -482,913 -11.33% ✗ $9.9M
Apr 19, 2023 Apr 21, 2023 TELA Bio, Inc. 10% Owner Sell 17.5 -192,000 -6.34% ✗ $1.8M
Apr 13, 2023 Apr 17, 2023 Galecto, Inc. 10% Owner Sell 32.5 -68,481 -0.63% ✗ $128.3K
Apr 10, 2023 Apr 12, 2023 Galecto, Inc. 10% Owner Sell 32.5 -67,537 -0.61% ✗ $121.4K
Apr 5, 2023 Apr 7, 2023 Galecto, Inc. 10% Owner Sell 22.5 -102,630 -1.37% ✗ $222K
Feb 15, 2023 Feb 17, 2023 Disc Medicine, Inc. Director Buy 95.0 +108,696 5.03% ✗ $2.5M
Dec 23, 2022 Dec 28, 2022 Terns Pharmaceuticals, Inc. Director Buy 90.0 +137,931 2.91% ✗ $1000K
Dec 22, 2022 Dec 27, 2022 Verona Pharma plc Director Sell 15.0 -6,139,864 -15.26% ✗ $136M
Nov 25, 2022 Nov 29, 2022 scPharmaceuticals Inc. 10% Owner Buy 100.0 +762,380 16.70% ✗ $4M
Nov 8, 2022 Nov 10, 2022 Compass Therapeutics, Inc. Director Buy 92.5 +402,000 2.71% ✗ $1.3M
Sep 16, 2022 Sep 16, 2022 Edgewise Therapeutics, Inc. Director Buy 92.5 +484,496 3.59% ✗ $5M
Aug 16, 2022 Aug 18, 2022 Terns Pharmaceuticals, Inc. Director Buy 100.0 +3,690,000 97.33% ✗ $8.9M
Jun 24, 2022 Jun 28, 2022 Arcutis Biotherapeutics, Inc. 10% Owner Sell 16.3 -341,971 -7.97% ✗ $7.3M
Jun 22, 2022 Jun 24, 2022 ImageneBio, Inc. Director Sell 17.5 -252,225 -1.83% ✗ $1.1M
May 26, 2022 May 31, 2022 PMV Pharmaceuticals, Inc. 10% Owner Sell 20.0 -26,253 -23.02% ✗ $418.2K
May 18, 2022 May 20, 2022 Edgewise Therapeutics, Inc. Director Buy 85.0 +138,000 1.03% ✗ $995K
May 11, 2022 May 13, 2022 Compass Therapeutics, Inc. Director Buy 85.0 +192,516 1.32% ✗ $420.5K
May 6, 2022 May 10, 2022 Compass Therapeutics, Inc. Director Buy 72.5 +125,359 0.86% ✗ $197.3K
May 3, 2022 May 5, 2022 Passage BIO, Inc. 10% Owner Buy 95.0 +525,000 8.31% ✗ $1M
Jan 20, 2022 May 5, 2022 Passage BIO, Inc. 10% Owner Buy 75.0 +50,800 0.81% ✗ $254K
Apr 6, 2022 Apr 8, 2022 Arcutis Biotherapeutics, Inc. 10% Owner Sell 15.0 -878,200 -6.06% ✗ $18.2M
Mar 29, 2022 Mar 31, 2022 PMV Pharmaceuticals, Inc. 10% Owner Sell 15.0 -474,500 -100.00% ✗ $10.3M
Jan 25, 2022 Jan 27, 2022 89bio, Inc. 10% Owner Sell 30.0 -70,573 -0.95% ✗ $592.4K
Jan 20, 2022 Jan 24, 2022 Passage BIO, Inc. 10% Owner Buy 95.0 +369,100 5.89% ✗ $2M
Jan 14, 2022 Jan 20, 2022 Passage BIO, Inc. 10% Owner Buy 90.0 +168,300 2.76% ✗ $905.2K
Jan 11, 2022 Jan 13, 2022 Passage BIO, Inc. 10% Owner Buy 90.0 +150,000 2.52% ✗ $841.1K
Dec 29, 2021 Dec 30, 2021 Janux Therapeutics, Inc. Director Sell 20.0 -40,400 -1.60% ✗ $820.1K
Dec 21, 2021 Dec 23, 2021 Janux Therapeutics, Inc. Director Sell 17.5 -119,400 -4.51% ✗ $2.3M
Dec 16, 2021 Dec 17, 2021 Janux Therapeutics, Inc. Director Sell 16.3 -393,300 -12.93% ✗ $7.5M
Nov 4, 2021 Nov 8, 2021 Compass Therapeutics, Inc. Director Buy 100.0 +5,357,143 42.13% ✗ $18.8M
Sep 20, 2021 Sep 22, 2021 Corvus Pharmaceuticals, Inc. Director Sell 16.3 -1,109,644 -13.78% ✗ $6.8M
Sep 3, 2021 Sep 8, 2021 Repare Therapeutics Inc. Director Sell 47.5 -8,084 -0.12% ✓ $274.8K
Aug 31, 2021 Sep 2, 2021 Repare Therapeutics Inc. Director Sell 43.8 -37,864 -0.38% ✓ $1.3M
Aug 26, 2021 Aug 30, 2021 Repare Therapeutics Inc. Director Sell 47.5 -18,073 -0.18% ✓ $615.7K
Aug 23, 2021 Aug 25, 2021 Repare Therapeutics Inc. Director Sell 47.5 -18,215 -0.18% ✓ $622.4K
Aug 17, 2021 Aug 19, 2021 Repare Therapeutics Inc. Director Sell 46.3 -20,328 -0.30% ✓ $693.2K
Jul 16, 2021 Jul 23, 2021 Enliven Therapeutics, Inc. Director Buy 100.0 +1,666,666 65.81% ✗ $10M
Jul 16, 2021 Jul 16, 2021 Enliven Therapeutics, Inc. Director Buy 100.0 +1,666,666 100.00% ✗ $10M
Jun 15, 2021 Jun 16, 2021 Janux Therapeutics, Inc. Director Buy 100.0 +705,853 30.20% ✗ $12M
Apr 21, 2021 Apr 23, 2021 NeuroPace Inc 10% Owner Buy 100.0 +235,000 100.00% ✗ $4M
Mar 30, 2021 Apr 13, 2021 ImageneBio, Inc. Director Buy 100.0 +423,400 27.98% ✗ $6.8M
Mar 30, 2021 Apr 1, 2021 ImageneBio, Inc. Director Buy 100.0 +423,400 22.46% ✗ $6.8M